The promoter of the Streptococcus pneumoniae putative fuculose kinase gene (fcsK), the first gene of a novel fucose utilization operon, is induced by fucose and repressed by glucose or sucrose. When the streptococcal polypeptide deformylase (PDF) gene (def1, encoding PDF) was placed under the control of P fcsK , fucosedependent growth of the S. pneumoniae (P fcsK ::def1) strain was observed, confirming the essential nature of PDF in this organism. The mode of antibacterial action of actinonin, a known PDF inhibitor, was also confirmed with this strain. The endogenous fuculose kinase promoter is a tightly regulated, titratable promoter which will be useful for target validation and for confirmation of the mode of action of novel antibacterial drugs in S. pneumoniae.Streptococcus pneumoniae is a widespread human pathogen and a major cause of community-acquired diseases such as pneumonia, otitis media, sinusitis, and meningitis (12). Established antibiotic treatments of pneumococcal infections have become less effective due to the emergence of drug-resistant isolates (34). A genomics-based strategy has been applied in the search for new drug targets to identify inhibitors active against this pathogen (25,33). Once a lead antimicrobial compound has been discovered, it is fundamentally important to demonstrate that during chemical optimization the antibacterial activity continues to be related to inhibition of the specific target (25). Tightly regulated, titratable promoter systems that are able to modulate the levels of the protein target have proven to be invaluable tools for tracking the mechanism of antibacterial activity of novel inhibitors (2, 37). In addition, inducible promoters have been used in antimicrobial drug discovery for establishing gene essentiality and characterizing the function of essential drug targets (1, 9, 31). For S. pneumoniae only a limited number of regulated promoters have been studied. Heterologous promoter systems derived from nisin and tetracycline genes have been analyzed as tools for regulating gene expression, but their narrow titratable range and high basal levels of expression have compromised their use (1, 2, 7). The streptococcal promoter of the maltose operon has been characterized at the molecular level and shown to be inducible by maltose and repressible by sucrose in S. pneumoniae (23), but its use has been limited by its high basal expression levels.More recently, the raffinose operon has been identified and its promoter has been shown to be regulated, though its application for target validation or mode-of-action analysis has yet to be demonstrated (27). The expression of genes involved in sugar metabolism is known to be a regulated process in many bacterial species. With the availability of genomic sequence data for S. pneumoniae, it is now possible to identify and study many, and perhaps all, putative sugar metabolic genes and their associated promoter sequences.Identification and bioinformatic analysis of the fucose gene cluster of S. pneumoniae. In an attempt to ident...